| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2573714 | Trends in Pharmacological Sciences | 2006 | 7 Pages |
Abstract
DNA-damaging agents have a central role in non-surgical cancer treatment. The balance between DNA damage and repair determines the final therapeutic consequences. An elevated DNA-repair capacity in tumor cells leads to drug or radiation resistance and severely limits the efficacy of these agents. Interference with DNA repair has emerged as an important approach in combination therapy against cancer. Anticancer targets in DNA-repair systems have emerged, against which several small-molecule compounds are currently undergoing clinical trials.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Jian Ding, Ze-Hong Miao, Ling-Hua Meng, Mei-Yu Geng,